Cleared Traditional

K061871 - LEICA MODEL FL800

K061871 is an FDA 510(k) clearance for LEICA MODEL FL800, manufactured by Leica Microsystems, Inc.. The device is a Class 2 Radiology device with product code IZI cleared through the Traditional 510(k) pathway after a 79-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2006
Decision
79d
Days
Class 2
Risk

K061871 is an FDA 510(k) clearance for the LEICA MODEL FL800. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Leica Microsystems, Inc. (Park City, US). The FDA issued a Cleared decision on September 20, 2006 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Leica Microsystems, Inc. devices

FDA 510(k) Submission Details - K061871

510(k) Number K061871 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2006
Decision Date September 20, 2006
Days to Decision 79 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 107d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IZI Device Classification - Class 2, Special Controls

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 144
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K061871.
DAR-9400F
K072006 · Shimadzu Corp. · Aug 2007
GE OEC ALTITUDE
K071717 · Shimadzu Corp. · Jul 2007
BRANSIST SAFIRE
K062360 · Shimadzu Corp. · Oct 2006
XPERCT
K060749 · Philips Medical Systems North America Co. · Apr 2006
DAR-8000F
K052500 · Shimadzu Medical Systems · Oct 2005
DAR-8000I
K052076 · Shimadzu Medical Systems · Sep 2005